SCHEMBL739873

SCHEMBL739873

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccoc3)n[nH]c2s1)c1ccccc1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AURKA O14965 4/20 0.48
ABL1 P00519 2/20 0.46
BCR P11274 2/20 0.46
KCNK3 O14649 1/20 0.39
KCNK9 Q9NPC2 1/20 0.39
ADORA3 P0DMS8 1/20 0.36
IMPDH2 P12268 1/20 0.36
USP36 Q9P275 1/20 0.35
TACR3 P29371 1/20 0.35
ROCK2 O75116 1/20 0.35
ROCK1 Q13464 1/20 0.35
FGFR1 P11362 1/20 0.34
FGFR2 P21802 1/20 0.34
FGFR3 P22607 1/20 0.34
CDK7 P50613 2/20 0.34
EGLN1 Q9GZT9 2/20 0.34
PTK2 Q05397 1/20 0.34
HDAC6 Q9UBN7 1/20 0.34
LCK P06239 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1779492 0.94 AURKA (0.44) AURKAABL1BCRPTK2
SCHEMBL740292 0.89 AURKA (0.55) AURKAABL1BCRKCNK9IMPDH2
SCHEMBL740809 0.86 AURKA (0.52) AURKAABL1BCRKCNK3IMPDH2
SCHEMBL741311 0.85 AURKA (0.53) AURKAABL1BCRADORA3IMPDH2
SCHEMBL738866 0.85 AURKA (0.53) AURKAABL1BCRKCNK3KCNK9
SCHEMBL743086 0.84 AURKA (0.45) AURKAABL1BCRADORA3
SCHEMBL741044 0.84 AURKA (0.51) AURKAABL1BCRKCNK3KCNK9
SCHEMBL739779 0.83 AURKA (0.52) AURKAABL1BCRROCK2ROCK1
SCHEMBL740955 0.83 CDK7 (0.48) AURKAABL1BCRKCNK3IMPDH2
SCHEMBL742124 0.83 AURKA (0.48) AURKAABL1BCRKCNK3USP36

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed